All In Biotech

Drug Trial Radar · NCT01800825

Clindamycin to Reduce Preterm Birth in a Low Resource Setting

Clindamycin to Reduce Preterm Birth in a Low Resource Setting: A Randomized Placebo-controlled Trial

Last checked: Nov 19, 2026Latest source record: Jul 18, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,726 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,726

Actual

Start

Jul 2013

Primary completion

Apr 2016

Study completion Apr 2016

Sponsor

Lead sponsor
Christiana Care Health ServicesAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Jawaharlal Nehru Medical College; Thrasher Research Fund
First posted
Feb 28, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
Female only, from 13 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Preterm birth has been linked to certain types of vaginal infections. The goal of this study is to determine if giving women pregnant between 13-20 weeks with an elavated vaginal pH(evidence of this type of infection)Oral Clindamycin(an antibiotic)will have a lower rate of preterm birth compared to women given a placebo(starch)

Conditions

  • Pregnancy
  • Prematurity
  • Preterm Birth
  • Bacterial Vaginosis

Interventions

  • ClindamycinDrug

    Clindamycin 300 mg Orally will be administered twice daily for a total of 5 days

  • PlaceboDrug

    This will be an identical placebo comparator made of starch.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Preterm birth prior to 37 weeksTime frame: Time of birth

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Jawaharlal Nehru Medical College

    Belagavi, Karnataka, India

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.